There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are ...

The social media content creator documents her fitness journey and learning 260K followers. In one of her posts she opened up ...

A new report from Renub Research forecasts that the diabetes device market in China will grow from US$6.22 billion in 2023 to US$12.74 billion by 2032, representing a compound annual growth rate (CAGR ...

Robbie Williams has poked fun at the ABC and Aussies after he got "in trouble" for promoting his new biopic Better Man.

Robbie Williams made a joke about Ozempic as the singer compared the size of his bottom to his Better Man co ... Use precise ...

Indian pharmaceutical sector faces new challenges in 2025, from UCPMP implementation to global dynamics and opportunities in ...

The health risks of too much sugar have been made clear, but the billion-dollar global market to supply it is thriving. Sales of sweet treats remain strong, and waistlines keep expanding. Could weight ...

Make 2025 the year you lose weight but also get strong and lean. Lose the moobs and the belly fat, the love handles and the ...

Life expectancy in the U.S. made an unusually sharp increase as deaths from most major causes declined, according to the latest Centers for Disease Control and Prevention report. Americans can expect ...

Dr Jagadish Hiremath, a public health intellectual, says, “The normalisation of GLP-1 agonists like Ozempic and Wegovy as ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...